Radiological characteristics of hepatocellular carcinoma that achieved complete response after chemoembolization with drug-eluting beads for liver transplantation planning

被引:0
|
作者
Valle, Leonardo Guedes Moreira [1 ]
Cunha, Marcela Juliano Silva [1 ]
Schmid, Bruno Pagnin [1 ]
Falsarella, Priscila Mina [1 ]
de Rezende, Marcelo Bruno [1 ]
Felga, Guilherme Eduardo Goncalves [1 ]
Ogawa, Renata Emy [1 ]
Garcia, Rodrigo Gobbo [1 ]
Affonso, Breno Boueri [1 ]
Nasser, Felipe [1 ]
Galastri, Francisco Leonardo [1 ]
机构
[1] Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil
来源
EINSTEIN-SAO PAULO | 2023年 / 21卷
关键词
Living donors; Liver neoplasms; Carcinoma; hepatocellular; Chemoembolization; therapeutic; Neoadjuvant therapy; Response evaluation criteria in solid tumors; Radiology; interventional; TRANSARTERIAL CHEMOEMBOLIZATION;
D O I
10.31744/einstein_journal/2023AO0307
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe the radiological characteristics of hepatocellular carcinoma (HCC) lesions that achieved a complete response following drug-eluting bead transarterial chemoembolization (DEB-TACE) preceding liver transplantation. Methods: This single-center case-control study enrolled patients with hepatocellular carcinoma who underwent neoadjuvant DEB-TACE therapy, were followed up with contrast-enhanced magnetic resonance imaging or computed tomography, and were successively evaluated according to the modified Response Evaluation Criteria in Solid Tumors. The HCCs were divided into two groups based on their diameter (Group A: <= 3cm; Group B: 3cm). Viability was assessed using the Kaplan-Meier method according to tumor size categories. The relationship between tumor variables was analyzed using bivariate Cox regression.Results: Three-hundred and twenty-eight patients with 667 hepatocellular carcinomas who underwent their first DEB-TACE session were enrolled. A total of 105 hepatocellular carcinomas in 59 patients exhibited complete response after the initial DEB-TACE session and were divided into Group A (92 HCCs) and Group B (13 HCCs). The diameter in Group A decreased significantly compared to the pre-procedure size until the second assessment (p<0.001), with no subsequent reduction in diameter, despite maintaining a complete response. In Group B, the reduction in diameter remained significant compared with the initial value until the sixth imaging evaluation (p=0.014). The average reduction was 45.1% for Group B and a maximum of 14.9% in Group A.Conclusion: HCCs >3cm exhibited a greater reduction in size and a longer time to recurrence. HCCs <= 3cm had a shorter relapse time. The recurrence rates were similar. These findings may aid in planning for liver transplantation.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
    Hee Chul Nam
    Bohyun Jang
    Myeong Jun Song
    World Journal of Gastroenterology, 2016, (40) : 8853 - 8861
  • [2] Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma
    Nam, Hee Chul
    Jang, Bohyun
    Song, Myeong Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (40) : 8853 - 8861
  • [3] Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma
    Guillaume Vesselle
    Camille Quirier-Leleu
    Stéphane Velasco
    Florian Charier
    Christine Silvain
    Samy Boucebci
    Pierre Ingrand
    Jean-Pierre Tasu
    European Radiology, 2016, 26 : 1640 - 1648
  • [4] Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma
    Vesselle, Guillaume
    Quirier-Leleu, Camille
    Velasco, Stephane
    Charier, Florian
    Silvain, Christine
    Boucebci, Samy
    Ingrand, Pierre
    Tasu, Jean-Pierre
    EUROPEAN RADIOLOGY, 2016, 26 (06) : 1640 - 1648
  • [5] Acute Pancreatitis after Transarterial Chemoembolization of Hepatocellular Carcinoma with Drug-Eluting Beads
    Green, Tyler J.
    Gipson, Matthew G.
    SEMINARS IN INTERVENTIONAL RADIOLOGY, 2015, 32 (01) : 18 - 21
  • [6] A Lethal Complication after Transarterial Chemoembolization with Drug-Eluting Beads for Hepatocellular Carcinoma
    Toro, Adriana
    Bertino, Gaetano
    Arcerito, Maria Concetta
    Mannnino, Maurizio
    Ardiri, Annalisa
    Patane', Domenico
    Di Carlo, Isidoro
    CASE REPORTS IN SURGERY, 2015, 2015
  • [7] The Efficiency of Transarterial Chemoembolization with Drug-Eluting Beads in Hepatocellular Carcinoma
    Kucukkapan, Ahmet
    Karakose, Serdar
    EUROPEAN JOURNAL OF GENERAL MEDICINE, 2015, 12 (01): : 44 - 52
  • [8] A case of drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma
    Guan, Qingbo
    Song, Lei
    Wang, Kuiyang
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (04) : 1172 - 1174
  • [9] ASSESSMENT OF TUMOR NECROSIS FOLLOWING CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA IN LIVER TRANSPLANTATION: POSSIBLE BENEFIT OF DRUG-ELUTING BEADS
    Alsina, Angel
    Franco, Edson S.
    Rojas, Haydy
    Brantley, Stephen
    Davis, Cliff
    Zwiebel, Bruce
    Neff, Guy
    HEPATOLOGY, 2011, 54 : 1395A - 1395A
  • [10] Transarterial chemoembolization with drug-eluting beads in patients with hepatocellular carcinoma: response analysis with mRECIST
    Domaratius, Claudia
    Settmacher, Utz
    Malessa, Christina
    Teichgraeber, Ulf
    DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2021, 27 (01) : 85 - 93